Swee Lay Thein
For their discovery of the genetic and molecular mechanisms underlying the fetal-to-adult hemoglobin switch, making possible a revolutionary and highly effective genome-editing therapy for sickle cell anemia and β thalassemia, devastating blood diseases that affect millions of people worldwide.
Affilié au moment de l'attribution du prix
National Heart, Lung, and Blood Institute, National Institutes of Health
Bethesda, États-Unis